Skip to main content

Month: September 2023

Ryman Hospitality Properties, Inc. Declares Third Quarter Dividend

NASHVILLE, Tenn., Sept. 18, 2023 (GLOBE NEWSWIRE) — Ryman Hospitality Properties (NYSE: RHP) (the “Company”), today announced that the Board of Directors has authorized, and the Company has declared a third quarter cash dividend of $1.00 per common share, to be paid on October 16, 2023, to stockholders of record as of September 29, 2023. About Ryman Hospitality Properties, Inc.Ryman Hospitality Properties, Inc. (NYSE: RHP) is a leading lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and entertainment experiences. The Company’s holdings include Gaylord Opryland Resort & Convention Center; Gaylord Palms Resort & Convention Center; Gaylord Texan Resort & Convention Center; Gaylord National Resort & Convention Center; and Gaylord Rockies Resort & Convention...

Continue reading

Volcon, Inc. Announces Improved Debt Position and Strategic Cost Reduction

NASDAQ: VLCN – Volcon, Inc. Announces Improved Debt Position and Strategic Cost ReductionVolcon ePowersports new Stag Limited Edition trim level in LTD TanAUSTIN, Texas, Sept. 18, 2023 (GLOBE NEWSWIRE) — Volcon Inc. (NASDAQ: VLCN), (“Volcon” or the “Company”), the first all-electric, off-road powersports company, announced on September 14, 2023 that it has agreed with its convertible noteholders to modify the terms of its convertible notes and implemented cost reduction strategies to provide the Company greater flexibility as it pushes toward the introduction of the first of its UTV models, the Stag, which the Company expects to begin delivering in October 2023. The Company entered into a note amendment with its convertible noteholders pursuant to which the lenders agreed to, among other changes, extend the...

Continue reading

Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression

SEATTLE, Sept. 18, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today a research agreement with Fred Hutchinson Cancer Center to evaluate VISTA expression as a potential biomarker in cancer patients from Kineta’s ongoing Phase 1/2 clinical trial evaluating KVA12123, the company’s VISTA blocking immunotherapy, alone and in combination with pembrolizumab. The primary objective is to evaluate VISTA as a biomarker to guide patient selection and treatment optimization for VISTA-targeted therapies where no standardized scoring method currently exists. Similar to standards established for PD-L1 immune checkpoint, there is a need to quantify VISTA expression in the tumor microenvironment...

Continue reading

Gildan Announces Participation in the Scotiabank Back to School Conference

MONTREAL, Sept. 18, 2023 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) announces today that Rhodri J. Harries, Executive Vice-President, Chief Financial and Administrative Officer and Chuck Ward, President, Sales, Marketing, and Distribution will participate in a fireside chat and one-on-one meetings with investors at the 27th Scotiabank Annual Back to School Conference in Toronto on September 20, 2023. About GildanGildan is a leading manufacturer of everyday basic apparel which markets its products in North America, Europe, Asia Pacific, and Latin America, under a diversified portfolio of Company-owned brands, including Gildan®, American Apparel®, Comfort Colors®, GOLDTOE®, Peds®, in addition to the Under Armour® brand through a sock licensing agreement providing exclusive distribution rights in the United States...

Continue reading

Blink Charging Announces Corporate Leadership Promotions, Naming Mike Battaglia COO, Jim Nemec CRO and Siddhartha Kodgi VP Operations

EV Charging Leader Builds Upon Synergies, Production and Cost Efficiencies as Electric Vehicle Market Continues to Expand Globally Miami Beach, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink”), a global leading manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announced the Blink Board of Directors has approved changes made to Blink’s executive leadership team with the appointment of Michael Battaglia, (formerly Chief Revenue Officer) as Chief Operations Officer; Jim Nemec, (formerly VP Sales and Business Development) as Chief Revenue Officer; and Siddhartha Kodgi, (formerly Sr. Director Operations) as Vice President of Operations. The Company also announced the departure of Mark Pastrone from his role as Chief Operations Officer. Following...

Continue reading

Ohmyhome Ltd. Announces Fall 2023 Investor Conferences and Events Participation

SINGAPORE, Sept. 18, 2023 (GLOBE NEWSWIRE) — Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property solutions and services for buying, selling, renting, and renovating homes, is pleased to announce its participation at the following upcoming investor events: September 2023:       1.   Skyline Signature Series™ Virtual Webinar Date: September 19, 2023Time: 12:00 pm ETLocation: Virtual Register: https://us02web.zoom.us/webinar/register/3216946143971/WN_3LwL4Iz-ThSF4aSM9n8x9A       2.   Maxim Group Tech Conference Series: Emerging Growth in A.I. Date:        September 26, 2023Time:        8:30 am ETLocation: Virtual October 2023:       1.   LD Micro Main Event XVI Conference Date: October 3-5, 2023Time: 3:00 pm PT presentation on October 4, 2023Location: Luxe Sunset...

Continue reading

Canadian North Resources Announces the Completion of 21,126 meter Diamond Drilling on its 100% Owned Ferguson Lake Project in Canada

Figure 1Map showing all the drill holes completed in 2023 at the Ferguson Lake project.Figure 2The Extensions of West Zone and East Zone as defined by the drill holes completed in the springs of 2022 and 2023 in addition to historic drill holes.Highlights:2023 planned 20,000-meter drill program successfully completed with 21,126 metres in total drilled during the year. 69 out of 78 holes intersected semi-massive to massive sulphides containing nickel, copper, cobalt, palladium and platinum. Assays results received for samples from the first 21 holes, e.g., 10.0m (from 47.57 – 57.57m) at 0.89% Cu, 0.53% Ni, 0.08% Co, 1.05g/t Pd, 0.12g/t Pt and 0.02 g/t Rh (July 18, 2023 News Release). Over 3,200 samples from the remaining 57 drill holes submitted to ALS labs with results pending.TORONTO, Sept. 18, 2023 (GLOBE...

Continue reading

Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Simufilam in On-Going Phase 3 Clinical Trials. The DSMB Recommended the Phase 3 Trials of Simufilam Continue as Planned, Without ModificationAUSTIN, Texas, Sept. 18, 2023 (GLOBE NEWSWIRE) —  Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced a positive interim safety review of simufilam in on-going Phase 3 clinical trials in patients with Alzheimer’s disease. A routine, scheduled meeting of a Data and Safety Monitoring Board (DSMB) recommended that both of Cassava Sciences’ Phase 3 studies of simufilam continue as planned, without modification. “I think this first interim safety review is an important milestone for the clinical development of simufilam,”...

Continue reading

Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference

Loughborough, England, Sept. 18, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present business updates and developments at the Maxim Group Emerging Growth in A.I., virtual conference. The presentation will take place at 11am Eastern time on 27 September 2023. Register for the conference here: www.m-vest.com About Nemaura Medical, Inc. Nemaura Medical Inc. is a medical technology company developing and commercialising non-invasive wearable diagnostic devices. The Company is currently also commercialising sugarBEAT® and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive...

Continue reading

Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology

Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction.Upon successful completion of the transaction, the resulting entity will continue the business of Atriva Therapeutics.Shareholders of Atriva will receive not less than 75% of the securities of the resulting issuer, with the current shareholders of Biocure Technology holding the remainder.The transaction is subject to various terms and conditions, including satisfactory due diligence, successful implementation of a private placement and shareholder approvals.TÜBINGEN, Germany and MUNICH, Germany, Sept. 18, 2023 (GLOBE NEWSWIRE) — Atriva Therapeutics GmbH (“Atriva”) is pleased to disclose the signing of an exclusive letter agreement, dated September 14, 2023, with Biocure Technology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.